- Home
- MOD vs RYTM Comparison
MOD vs RYTM Comparison
Compare MOD & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOD
- RYTM
- Stock Information
- Founded
- MOD 1916
- RYTM 2008
- Country
- MOD United States
- RYTM United States
- Employees
- MOD N/A
- RYTM N/A
- Industry
- MOD Auto Parts:O.E.M.
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- MOD Consumer Discretionary
- RYTM Health Care
- Exchange
- MOD Nasdaq
- RYTM Nasdaq
- Market Cap
- MOD 4.9B
- RYTM 4.3B
- IPO Year
- MOD N/A
- RYTM 2017
- Fundamental
- Price
- MOD $99.52
- RYTM $89.00
- Analyst Decision
- MOD Strong Buy
- RYTM Strong Buy
- Analyst Count
- MOD 5
- RYTM 13
- Target Price
- MOD $135.50
- RYTM $80.08
- AVG Volume (30 Days)
- MOD 829.2K
- RYTM 806.9K
- Earning Date
- MOD 07-29-2025
- RYTM 08-05-2025
- Dividend Yield
- MOD N/A
- RYTM N/A
- EPS Growth
- MOD 12.87
- RYTM N/A
- EPS
- MOD 3.42
- RYTM N/A
- Revenue
- MOD $2,583,500,000.00
- RYTM $136,863,000.00
- Revenue This Year
- MOD $6.68
- RYTM $37.56
- Revenue Next Year
- MOD $9.36
- RYTM $74.99
- P/E Ratio
- MOD $28.92
- RYTM N/A
- Revenue Growth
- MOD 7.30
- RYTM 48.88
- 52 Week Low
- MOD $64.79
- RYTM $40.61
- 52 Week High
- MOD $146.84
- RYTM $88.92
- Technical
- Relative Strength Index (RSI)
- MOD 54.33
- RYTM 82.22
- Support Level
- MOD $97.87
- RYTM $64.65
- Resistance Level
- MOD $105.54
- RYTM $67.75
- Average True Range (ATR)
- MOD 3.61
- RYTM 2.88
- MACD
- MOD -0.11
- RYTM 1.71
- Stochastic Oscillator
- MOD 53.70
- RYTM 99.82
About MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.